Search results
Results From The WOW.Com Content Network
Cologuard is an at-home colon cancer screening kit that detects changes in genetic material indicating potential cancer or polyps. Medicare covers one kit per year under Original Medicare (Parts A ...
Lighter Side. Medicare. News
The test is Guardant Health’s Shield blood test, and the approval is a critical step towards making it available to the general population. The approval came after a study published in the New ...
A positive test is almost always an indication to do a colonoscopy. In most cases the positive result is just due to hemorrhoids ; however, it can also be due to diverticulosis , inflammatory bowel disease ( Crohn's disease , ulcerative colitis ), colon cancer, or polyps .
Pre-existing condition exclusions prohibited in all health insurance plans; Prohibit treating acts of domestic violence as a pre-existing condition; Waiting period for enrollment in new health insurance plans limited to 90 days; Grandfathered existing health insurance plans must prohibit pre-existing condition exclusions by January 1, 2014
Exact Sciences Corp. is an American molecular diagnostics company based in Madison, Wisconsin specializing in the detection of early stage cancers. The company's initial focus was on the early detection and prevention of colorectal cancer; in 2014 it launched Cologuard, the first stool DNA test for colorectal cancer.
The Cologuard Plus test will build on the Cologuard test, which has been used more than 17 million times. The Cologuard test is a first-line colorectal cancer screening test for adults age 45 or ...
The false positive rate (FPR) is the proportion of all negatives that still yield positive test outcomes, i.e., the conditional probability of a positive test result given an event that was not present. The false positive rate is equal to the significance level. The specificity of the test is equal to 1 minus the false positive rate.